Acuta Capital Acquires Stake in Erasca (ERAS) with $4.19 Million Investment
On May 15, 2026, it was reported that Acuta Capital Partners initiated a new position in Erasca by purchasing 354,575 shares valued at approximately $4.19 million during the first quarter of 2026. The stake increased to an estimated value of $5.74 million as of March 31, 2026.
Tickers: $ERAS
Topics: Biotech ERAS Stock Institutional Investing